Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Financial Flexibility Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Financial Flexibility Index of 0.76x as of December 2024. Free cash flow of CN¥152.38 Million (operating CF CN¥47.07 Million minus capex CN¥105.31 Million) represents 1% of total liabilities (CN¥200.84 Million). Check cash flow reinvestment rate of Suzhou Fushilai Pharmaceutical Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow conversion.
Annual Financial Flexibility Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Suzhou Fushilai Pharmaceutical Co. Ltd.. Explore 301258 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.76x | CN¥152.38 Million | CN¥47.07 Million | CN¥200.84 Million | ▼ -5.2% |
| 2023 | 0.80x | CN¥136.39 Million | CN¥94.77 Million | CN¥170.45 Million | ▼ -15.8% |
| 2022 | 0.95x | CN¥201.30 Million | CN¥151.19 Million | CN¥211.75 Million | ▼ -22.9% |
| 2021 | 1.23x | CN¥280.48 Million | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.2% |
| 2020 | 1.40x | CN¥232.54 Million | CN¥166.85 Million | CN¥165.61 Million | ▲ +7.4% |
| 2019 | 1.31x | CN¥221.48 Million | CN¥150.55 Million | CN¥169.48 Million | — |